Paul Streck
Technik-/Wissenschafts-/F&E-Leiter bei ALBIREO PHARMA, INC.
Ursprung des Netzwerks ersten Grades von Paul Streck
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
26
| Subsidiary | Pharmaceuticals: Major | 26 |
| Subsidiary | Pharmaceuticals: Major | 20 | |
| Subsidiary | Pharmaceuticals: Major | 20 | |
| Public Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paul Streck
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer Corporate Officer/Principal | |
| ZURA BIO LIMITED | Biotechnology | Director/Board Member Chairman Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Chief Executive Officer | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Founder Chief Executive Officer | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President Public Communications Contact Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Founder Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor Comptroller/Controller/Auditor Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Chief Executive Officer Founder Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director/Board Member Director/Board Member Corporate Secretary General Counsel | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Founder Corporate Officer/Principal General Counsel | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Comptroller/Controller/Auditor Corporate Officer/Principal General Counsel | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Director/Board Member President | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact Human Resources Officer Corporate Officer/Principal | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Riverside | College/University | Undergraduate Degree Doctorate Degree | |
| University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Graduate Degree | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
US Pharmaceuticals, Inc.
 US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology US Pharmaceuticals, Inc. manufactures and distributes medicines. The private company is based in Seal Beach, CA. | Pharmaceuticals: Major | President Public Communications Contact | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Public Communications Contact Private Equity Investor | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| New York University | College/University | Undergraduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| NGEN INC | Medical Specialties | Director of Finance/CFO Founder | |
| CAREFUSION CORPORATION | Medical Distributors | Chief Executive Officer Human Resources Officer | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Iowa | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal General Counsel | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Director of Finance/CFO | |
| MIRATI THERAPEUTICS | Biotechnology | Human Resources Officer Director of Finance/CFO | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
| LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 40 |
| Vereinigtes Königreich | 5 |
| Frankreich | 4 |
| Deutschland | 3 |
| Schweden | 2 |
Sektoral
| Health Technology | 35 |
| Consumer Services | 12 |
| Consumer Non-Durables | 3 |
| Finance | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 329 |
| Corporate Officer/Principal | 173 |
| Independent Dir/Board Member | 122 |
| Chief Executive Officer | 63 |
| Undergraduate Degree | 62 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Myrtle Potter | 41 |
| Garry Neil | 38 |
| Tina Nova | 29 |
| Amit Munshi | 27 |
| Elizabeth Anderson | 25 |
| Mike Gutch | 24 |
| Olivier Jean Bohuon | 24 |
| Davey Scoon | 24 |
| David Chiswell | 23 |
| David Stout | 19 |
| Jennifer Jarrett | 18 |
| S. Mathew | 18 |
| Michele Galen | 17 |
| Kieran Gallahue | 17 |
| Christopher Cabell | 16 |
- Börse
- Insiders
- Paul Streck
- Unternehmensverbindungen